PTC Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PTCT Nasdaq 2834 www.ptcbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PTC Therapeutics, Inc.

PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference - Jan 12th, 2026 6:30 am
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 8th, 2026 2:30 pm
Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics’ (PTCT) Rare-Disease Strategy - Dec 23rd, 2025 12:04 am
PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch - Dec 22nd, 2025 11:07 pm
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan - Dec 22nd, 2025 5:00 am
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Dec 18th, 2025 6:00 am
PTC Therapeutics Announces Health Canada Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) - Dec 10th, 2025 6:00 am
PTC Therapeutics (PTCT): Revisiting Valuation After Strong Multi‑Year Share Price Gains - Dec 4th, 2025 4:16 am
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? - Dec 3rd, 2025 1:56 pm
PTC Therapeutics Investors Focus on Sephience Uptake, Huntington's Updates, RBC Says - Dec 3rd, 2025 10:31 am
Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You? - Dec 2nd, 2025 3:03 pm
Carvana initiated, Zscaler downgraded: Wall Street's top analyst calls - Dec 1st, 2025 7:46 am
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors - Dec 1st, 2025 7:00 am
How The Sephience Launch Is Reshaping The Story For PTC Therapeutics’s Valuation - Nov 29th, 2025 3:07 pm
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 - Nov 29th, 2025 9:28 am
SanDisk stock surges after S&P 500 inclusion announcement - Nov 24th, 2025 4:06 pm
Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600 - Nov 24th, 2025 4:01 pm
PTC Therapeutics to Host R&D Day - Nov 20th, 2025 6:00 am
PTC Therapeutics (PTCT) Profitability Rebound Challenges Bearish Narratives Despite Guidance for Steep Earnings Decline - Nov 6th, 2025 2:16 am
PTC Therapeutics Inc (PTCT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 4th, 2025 10:02 pm